Heteroplasmy and Copy Number in the Common m.3243A>G Mutation-A Post-Mortem Genotype-Phenotype Analysis

Leila Motlagh Scholle1, Stephan Zierz1, Christian Mawrin2

  • 1Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany.

Genes
|February 23, 2020
PubMed

Insights

Mitochondrial encephalopathy, lactate acidosis, and stroke-like episodes (MELAS) linked to m.3243A>G mutations show varied clinical outcomes. High mutation levels in tissues don't always cause disease, suggesting other factors influence severity.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neurology

Background:

  • Mitochondrial DNA (mtDNA) mutations, including m.3243A>G, cause MELAS, a disease with significant clinical variability.
  • The precise genetic mechanisms driving this heterogeneity in m.3243A>G-related mitochondrial diseases remain unclear.

Purpose of the Study:

  • To investigate genotype-phenotype correlations in patients with the m.3243A>G mutation.
  • To analyze the relationship between mtDNA heteroplasmy levels, mtDNA copy numbers, and clinical presentation.

Main Methods:

  • Genotype-phenotype correlation analysis in 16 patients (15 literature, 1 new case) with the m.3243A>G mutation.
  • Correlation of mtDNA copy numbers with heteroplasmy levels in 30 post-mortem tissue samples, including brain tissue.

Main Results:

  • In the central nervous system, higher heteroplasmy levels correlated with lower mtDNA copy numbers.
  • Skeletal muscle heteroplasmy levels showed significant correlations with kidney and liver tissues.
  • No significant difference in heteroplasmy levels was observed between clinically affected and unaffected patients.

Conclusions:

  • High mtDNA heteroplasmy levels in tissues do not automatically predict a specific phenotype.
  • Factors beyond heteroplasmy, such as mtDNA copy number and nuclear factors, likely influence disease severity in m.3243A>G mitochondrial diseases.